• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Emory Healthcare Taps Rimidi to Create FHIR-Based Apps for Orthopedic Surgery and Deep Brain Stimulation

Share:

March 4, 2021

What You Should Know:

– Rimidi, a cloud-based software platform that enables personalized management of health conditions across populations, today announced a strategic collaboration with Emory Healthcare to develop new patient and provider-facing FHIR apps.

– Specifically, the apps will create a more collaborative and transparent experience for patients undergoing orthopedic surgery, as well as for those referred to the deep brain stimulation (DBS) program for Parkinson’s and other neurologic conditions at Emory and other participating health systems.

– As early pioneers of SMART on FHIR, Rimidi’s apps work directly within leading EHR’s – no separate sign in, no workflow disruption and better clinical efficiency. Rimidi combines patient-generated health data from connected devices or patient reported outcomes measures with clinical data to drive patient-specific clinical insights and actions through embedded clinical decision support pathways.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Rimidi’s new FHIR-based Ortho and Deep Brain Stimulation Apps are currently implemented at Emory, and are now commercially available for additional leading hospitals and health systems across the U.S.

Source:

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • CannaRoyalty to acquire 180 Smoke for C$25 million in stockCannaRoyalty to acquire 180 Smoke for C$25 million in stock
  • Southworth Associates Proudly Announces AcquisitionSouthworth Associates Proudly Announces Acquisition
  • Aldena Raises $30M To Advance Skin-Deep siRNA TherapiesAldena Raises $30M To Advance Skin-Deep siRNA Therapies
  • SEHA Automates 70% of Its Services Following New WhatsApp IntegrationSEHA Automates 70% of Its Services Following New WhatsApp Integration
  • Predictive Health Diagnostics Company Expands Smart Science Diagnostics Platform with Acquisition of MUSE Microscopy Inc.Predictive Health Diagnostics Company Expands Smart Science Diagnostics Platform with Acquisition of MUSE Microscopy Inc.
  • Leidos to Acquire IMX Medical Management ServicesLeidos to Acquire IMX Medical Management Services
  • Immersive Experiences Could Help Educate Patients, Cut Down on Video Call FatigueImmersive Experiences Could Help Educate Patients, Cut Down on Video Call Fatigue
  • Pharmaceutical Packaging Market Size, Industry Demand, Regional Analysis & Insights 2027Pharmaceutical Packaging Market Size, Industry Demand, Regional Analysis & Insights 2027

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications